3702
A. K. Ghosh et al. / Tetrahedron Letters 53 (2012) 3699–3702
water and brine, then concentrated, and purified by flash column
Acknowledgments
chromatography to give 8a (6.27 g, 91%). 1H NMR (400 MHz, CDCl3); d 7.70–
7.00 (m, 14H), 5.02 (s, 2H). 13C NMR (100 MHz, CDCl3); d 142.8–127.4 (Ph), 31.0
3
(d, J1P-C = 16.4 Hz). 31P NMR (121 MHz, CDCl3); d 33.0 (s, 1P).
Financial support by the National Institute of Health is grate-
fully acknowledged. We thank Mr. Chad Keys (Purdue University)
for preliminary experimental assistance.
Preparation of (2-diphenylphosphinoyl)phenylmethyl-diphenylphosphine-borane
adduct (9): To a solution of Ph2P(BH3)H (4.06 g, 20.3 mmol) in THF (200 mL)
was added 12.8 mL n-BuLi (1.6 M in hexanes) dropwise over 10 min at À78 °C.
HMPA (200 mL) was added after 10 min and the resulting solution was stirred
for a further 10 min. Phosphine oxide 8a (6.27 g, 16.9 mmol) was added as a
solution in THF (56 mL) via cannula. After stirring for 20 min, the solution was
warmed to 25 °C over 40 min. The reaction was quenched with aqueous
(NH4)2SO4 and the reaction mixture was washed with water and brine.
Removal of the solvent provided a residue which was purified by flash column
chromatography. Recrystallization of the product from warm diethyl ether
furnished 9 (7.53 g, 91%). 1H NMR (400 MHz, CDCl3); d 7.92–6.88 (m, 24H), 4.39
Supplementary data
Supplementary data (1H, 11B, 13C, and 31P NMR spectra for all
new compounds) associated with this article can be found, in the
2
(d, J1PH = À12.8 Hz, 2H), 1.60–1.20 [q(br), 3H]. 11B NMR (96 MHz, CDCl3); d
À37.0 [s(br), 1B]. 13C NMR (100 MHz, CDCl3); d 139.0–126.1 (Ph), 30.8, (d,
1J1PC = 56.9 Hz). 31P NMR (121 MHz, CDCl3); d 33.9 (s, 1P), 18.3 [s(br), 1P]. LRMS
(ESI) (MÀH)+ = 489, M+ = 490, (MÀBH3+ONa)+ = 515.
References and notes
1. (a) Nakata, T. Chem. Rev. 2005, 105, 4314–4347; (b) Gademann, K.; Portmann, C.
Curr. Org. Chem. 2008, 12, 326–341.
2. (a) Carrillo, R.; Leon, L. G.; Martin, T.; Martin, V. S.; Padron, J. M. Bioorg. Med.
Chem. Lett. 2006, 16, 6135–6138; (b) Singh, P.; Bhardwaj, A. J. Med. Chem. 2010,
53, 3707–3717.
3. Ghosh, A. K.; Nicponski, D. R. Org. Lett. 2011, 13, 4328–4331.
4. Rychnovsky, S. D.; Jasti, R. J. J. Am. Chem. Soc. 2006, 128, 13640–13648.
5. Rychnovsky, S. D.; Tadpetch, K. Org. Lett. 2008, 10, 4839–4842.
6. Tolman, C. A. Chem. Rev. 1977, 77, 313–348.
7. Zhou, Q.-L.; Wang, A.-E.; Xie, J.-H.; Wang, L.-X. Tetrahedron 2005, 61, 259–266.
8. Imamoto, T.; Oshiki, T.; Onozawa, T.; Kusumoto, T.; Sato, K. J. Am. Chem. Soc.
1990, 112, 5244–5252.
Preparation of (2-diphenylphosphino)phenylmethyldiphenylphosphine-borane
adduct (10): Diphosphine-borane monoxide
9 (600 mg, 1.22 mmol) was
dissolved in THF (25 mL). Alane–THF adduct (ꢀ0.5 M, 1 equiv) was added
dropwise over 10 min at 0 °C. After stirring for 30 min, an additional equivalent
of alane was added, and the solution was warmed to room temperature over
1 h. Methanol was added to quench the excess alane, then the mixture was
passed through celite. The filtrate was concentrated, and the crude product
was purified by flash column chromatography to give pure 10 (560 mg, 96%) as
an amorphous solid. 1H NMR (400 MHz, CDCl3); d 7.72–6.78 (m, 24H), 4.03
4
2
[d(d), J1PH = À2.4 Hz, J2PH = À11.6 Hz, 2H], 1.59–0.95 [d(d{br}), 3H]. 11B NMR
(96 MHz, CDCl3); d À37.3 [s(br), 1B]. 13C NMR (100 MHz, CDCl3); d 137.4–127.4
(Ph), 31.2, [d(d), 3J1PC = 25.2 Hz, 1J2PC = 31.2). 31P NMR (121 MHz, CDCl3); d 19.8
[s(br), 1P], À14.6 (s, 1P). LRMS (ESI) (M+H)+ = 475, (M+Na)+ = 497,
(M+K)+ = 513.
9. Carboni, B.; Monnier, L. Tetrahedron 1999, 55, 1197–1248.
10. Gaumont, A.-C.; Bourumeau, K.; Denis, J.-M. J. Organomet. Chem. 1997, 529,
205–213.
Preparation of 1-(diphenylphosphino)-2-(diphenylphosphinomethyl)benzene (bis-
DPPMB) (L3): Diphosphine–borane adduct 10 (250 mg, 0.527 mmol) was
dissolved in 35 mL diethylamine. After stirring for 12 h, 100 ml H2O was
added, and the product was extracted with EtOAc. After concentrating, the
crude bisphosphine was purified by silica gel plug filtration to give L3 in
quantitative yield. 1H NMR (400 MHz, CDCl3); d 7.94–6.81 (m, 24H), 3.74 (s,
2H). 13C NMR (100 MHz, CDCl3); d 138.4–126.4 (Ph), 34.6. 31P NMR (121 MHz,
11. (a) Hayashi, T.; Uozumi, Y. Pure Appl. Chem. 1992, 64, 1911–1916; (b)
Naumann, K.; Zon, G.; Mislow, K. J. Am. Chem. Soc. 1969, 91, 7012–7023.
12. Hamada, Y. et al Tetrahedron Lett. 1997, 38, 8961–8964.
13. Imamoto, T.; Kikuchi, S.-I.; Miura, T.; Wada, Y. Org. Lett. 2001, 3, 87–90.
14. (a) Imamoto, T.; Takeyama, T.; Kusumoto, T. Chem. Lett. 1985, 14, 1491–1492;
(b) Busacca, C. A.; Raju, R.; Grinberg, N.; Haddad, N.; James-Jones, P.; Lee, H.;
Lorenz, J. C.; Saha, A.; Senanayake, C. H. J. Org. Chem. 2008, 73, 1524–1531.
15. Brown, H. C.; Yoon, N. M. J. Am. Chem. Soc. 1966, 88, 1464–1472.
16. (a) Wyatt, P.; Griffin, S.; Heath, L. Tetrahedron Lett. 1998, 39, 4405–4406; (b)
Wyatt, P.; Bootle-Wilbraham, A.; Head, S.; Longstaff, J. Tetrahedron Lett. 1999,
40, 5267–5270.
17. Imamoto, T.; Kusumoto, T.; Suzuki, N.; Sato, K. J. Am. Chem. Soc. 1985, 107,
5301–5303.
18. Single-crystal X-ray analysis was performed in-house. Dr. Phil Fanwick, X-Ray
Crystallography Laboratory, Department of Chemistry, Purdue University,
West Lafayette, IN, 47907.
19. CCDC 852880 contains the supplementary crystallographic data for compound
10. These data may be obtained free of charge from the Cambridge
20. All new compounds gave satisfactory spectroscopic and analytical results.
Preparation of 2-(bromomethyl)phenyl diphenylphosphine oxide (8a): O-
Tolyldiphenylphosphine oxide 7 (6.83 g, 23.4 mmol) was dissolved in 235 mL
benzene. NBS (4.24 g) and AIBN (385 mg) were added, and the solution was
refluxed for 40 h, then cooled to 25 °C. The reaction mixture was washed with
4
4
CDCl3); d À9.1 (d, 1P, J1PP = À24.0 Hz), À15.7 (d, 1P, J1PP = À24.0 Hz). HRMS
(ESI) m/z calcd for C31H26P2 461.1588, found 461.1583.
Synthesis of tetrahydropyran derivative 12: Cu(OTf)2 (43 mg, 0.12 mmol,
0.15 equiv) was added to a solution of bisphosphine L3 (55 mg, 0.12 mmol,
0.15 equiv) in CH2Cl2 (5 mL) under an argon atmosphere. This solution was
stirred for 1 h then 4-methoxybenzaldehyde 11 (136 mg, 1 mmol) and alkenol
1
(143 mg, 1.25 mmol) were added to the solution in CH2Cl2 (5 mL) via
cannula. After stirring for 18 h, the reaction mixture was diluted with CH2Cl2
and washed with aq NaHCO3 (20 mL) and brine (20 mL). The organic layer was
dried with Na2SO4 and concentrated. Crude THP was purified via column
chromatography to provide 12 (160 mg, 69%). 1H NMR (400 MHz, CDCl3); d
7.22 (d, J1 = 5.0 Hz, 2H), 6.82 (d, J1 = 5.0 Hz, 2H), 4.62 & 4.61 (s & s, 1H & 1H),
4.10 (m, 2H), 3.77 (s, 3H), 3.58 [t(d), J1 = 5.0, J2 = 2.3 Hz, 1H], 2.33 [t(d), J1 = 5.0,
J2 = 2.4 Hz, 1H], 1.92–1.71 (m, 4H), 1.43 (s, 3H). 13C NMR (100 MHz, CDCl3); d
159.0, 146.5, 133.5, 128.5, 113.4, 111.9, 84.0, 68.9, 55.2, 50.4, 30.4, 26.4, 21.5.
HRMS (EI/CI) m/z calcd for C15H20O2 232.1463, found 232.1465.